Folkman remembered as creative, kind

This afternoon, I spoke with Harold Dvorak, a colleague of Judah Folkman's at Harvard, who reacted to his colleague's linkurl:sudden passing;http://www.the-scientist.com/blog/display/54173/ yesterday. He said that he's spent the day thinking back over Folkman's generosity as a physician, not only his achievements as a pioneer in anti-angiogenesis therapy for cancer. Hundreds of patients contacted Folkman with problems - an incurable case of cancer, for instance - and he stayed i

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
This afternoon, I spoke with Harold Dvorak, a colleague of Judah Folkman's at Harvard, who reacted to his colleague's linkurl:sudden passing;http://www.the-scientist.com/blog/display/54173/ yesterday. He said that he's spent the day thinking back over Folkman's generosity as a physician, not only his achievements as a pioneer in anti-angiogenesis therapy for cancer. Hundreds of patients contacted Folkman with problems - an incurable case of cancer, for instance - and he stayed in touch with them, Dvorak said, adding that he hears "all the time" about patients who reached out to Folkman and received a personal response. "I don't know if he ever slept," what with running a large lab and keeping in contact with so many patients. "I've never known anybody quite like him," he added. Another one of Folkman's defining qualities was his ability to come up with novel ideas, Dvorak added. "He wasn't always right, but that's part of the risk of being novel," he said. "You'd never hear a talk by him without coming away with some new idea." He added: "Judah Folkman was one of the most creative men I've ever met. And one of the most creative scientists I've ever met." "Judah Folkman's passing is a tremendous and tragic loss for humankind," AACR Chief Executive Officer Margaret Foti said in a statement. "His legacy of discovery and ingenuity in the field of angiogenesis will continue to inspire cancer researchers and give hope to countless individuals living with the disease. He was certainly a valued friend of the AACR and we extend our deepest condolences to the Folkman family."
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Alison McCook

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours